Related Experiment Video
Updated: Oct 16, 2025

Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure
Published on: February 8, 2022
GORE® Cardioform ASD Occluder experience in transcatheter closure of "complex" atrial septal defects
Giuseppe Santoro1, Magdalena Cuman1, Alessandra Pizzuto1
1Pediatric Cardiology and GUCH Unit, Heart Hospital "G. Pasquinucci", National Research Council-Tuscany Foundation "G. Monasterio", Massa, Italy.
Insights
The GORE® Cardioform ASD Occluder (GCO) effectively and safely closes complex atrial septal defects (ASDs) in a high percentage of patients. This transcatheter approach offers a viable solution for challenging ASD cases.
Area of Science:
- Cardiology
- Medical Devices
- Interventional Cardiology
Background:
- Transcatheter closure of atrial septal defects (ASDs) presents challenges in complex clinical and anatomical scenarios.
- The GORE® Cardioform ASD Occluder (GCO) is a device designed for ASD closure.
Purpose of the Study:
- To evaluate the efficacy and safety of the GORE® Cardioform ASD Occluder (GCO) for transcatheter closure of complex atrial septal defects (ASDs).
Main Methods:
- A retrospective study involving 72 patients with significant ASDs between January 2020 and March 2021.
- Patients were categorized into "complex" (n=36) and "simple" (n=36) ASD groups based on anatomical and clinical criteria.
- Complex ASDs were defined by rim deficiency, large size relative to patient metrics, or multifenestrated septa.
Main Results:
- Complex ASDs were significantly larger and associated with higher Qp/Qs ratios compared to simple ASDs.
- Procedure and fluoroscopy times were longer for complex ASDs, with a lower procedure feasibility rate (94.4% vs. 100%) and a higher complication rate (13.9% vs. 0%).
- Successful closure was achieved in 92% of complex ASD cases, with complete closure rates at follow-up not significantly different between groups (97.1% vs. 100%).
Conclusions:
- Percutaneous transcatheter closure using the GCO device is an effective and safe treatment option for a high percentage of complex ASDs.
- The GCO device demonstrates feasibility and good early outcomes in challenging ASD anatomies.
- Despite a higher complication rate in complex cases, the overall success and closure rates are encouraging.
Objective:
To evaluate the GORE® Cardioform ASD Occluder (GCO) (WL Gore & Associates, Flagstaff, AZ) device for "complex" atrial septal defects (ASD) closure.
Background:
Transcatheter ASD closure is still challenging in "complex" clinical/anatomic settings. This study evaluated the results of GCO in closure of "complex" ASD in a tertiary referral center.
Methods:
Between January 2020 and March 2021, 72 patients with significant ASD were submitted to transcatheter closure with GCO at our Institution. Based on clinical/anatomic characteristics, they were classified as "complex" (n = 36, Group I) or "simple" (n = 36, Group II). We considered as "complex", defects with rim deficiency (< 5 mm) other than antero-superior, relatively large (diameter/patient weight > 1.2 or diameter/patient BSA > 20 mm/m2 ) or within a multifenestrated septum. Procedure results and early outcome were compared between the groups.
Results:
Absolute and relative ASD size (20 ± 4 vs. 15 ± 3 mm, p < 0.0001; 0.9 ± 0.3 vs. 0.4 ± 0.2 mm/kg, p < 0.0001; 23 ± 7 vs. 12 ± 5 mm/m2 , p < 0.0001), QP/QS (2.0 ± 0.8 vs. 1.4 ± 0.3, p < 0.001), procedure and fluoroscopy times (73 ± 36 vs. 43 ± 21 min, p < 0.0001; 16 ± 9 vs. 9 ± 4 min, p < 0.0001, procedure feasibility (94.4 vs. 100%, p < 0.0001) and overall complication rate (13.9 vs. 0%, p < 0.0001) were significantly different between the groups. Successful closure of "surgical" ASDs was achieved in 92% of cases. Complete closure at last follow-up evaluation did not significantly differ between the groups (97.1 vs. 100%, p = NS), as was wireframe fractures rate (49.1% in the overall population), without clinical, EKG and echocardiographic consequences.
Conclusions:
Percutaneous treatment with GCO device is effective and safe in high percentage of "complex" ASDs.
More Related Videos
Related Concept Videos
Cardiac Catheterization II: Right Heart Catheterization
Cardiac Catheterization III: Left Heart Catheterization
Aortic Regurgitation III: Medical Management
Mitral Stenosis I: Introduction
Aortic Regurgitation I: Introduction

